The objective of the present work was to develop and validate of an analytical method for the quantitative determination of Fexo. HCL and Pseudo. HCl in a combined tablet dosage form by U V − V is spectrophotometry and TLC. The main problem was to separate the two active ingredient from a single bilayered tablet because both the A.P.I's were soluble in the same solvents. As media selection, distilled water and ethanol (1 : 1) were used for Pseudo. HCl and methanol for Fexo. HCl, in which both the drugs were soluble and stable for a sufficient time. Both drugs were measured at 220nm and 247nm, where they showed maximum absorbance. Beer Lambert's law was obeyed at concentration range 4 − 14 ppm and 5 − 30 ppm for Fexo. HCl and Pseudo HCl respectively. Fexo. HCl (Y = 0.0643x + 0.9370) was measured with correlation coefficient r = 0.9574 and Pseudo. HCl (Y = 0.0843x + 0.0219) with correlation coefficient r = 0.9992. The results of analysis have been validated statistically and recovery studies were carried out as 99.29% ± 0.943 and 99.29% ± 0.941 which were close to the assay value 100.1% & 100.6 %. Precision of the method was measured which showed results for SD (99.57 % & 99. 51% ) and % RSD (99.53 % & 99.54). The proposed method may be suitably applied for the analysis of Fexo. HCl and Pseudo.HCl in tablet pharmaceutical formulation for routine analysis.
Introduction
Pseudoephedrine (Figure 1) is the most popular active nasal decongestant due to its effectiveness and relatively mild side effects [1] . In recent years, it has become increasingly difficult to obtain pseudoephedrine in many states because of its use as a precursor for the illegal drug N-methyl amphetamine (also known under various names including crystal meth, meth ice, etc.) [2] . Fexofenadine, (Figure 2 Figure 2 . Fexofenadine Fexofenadine is the active derivative of the antihistamine terfenadine, with no anti-cholinergic or alpha 1-adernergic receptor-blocking effects and without severe cardiac side effects of terfenadine [3, 4] . In literature survey many analytical methods have been reported for the estimating of individual Pseudoephedrine hydrochloride [5, 6] , few HPLC assay and dissolution methods have been reported for determination of fexofenadine in pharmaceutical preparation [7] . The estimation of fexofenadine in biological fluids using liquid chromatography with mass spectrometry [8] , ionspray tandem mass spectrometry [9] , electronspray tandem mass spectrometry [10] , UV detection [11, 1] The published method on HPLC was time taking and expensive for the routine analysis of pharmaceutical sectors. However, we have made an attempt to separate both the drugs by Thin Layer Chromatography and estimate it by UV-Visible spectrophotometer which is more reliable and economical. However, no work has so far been carried out for the simultaneous determination of Fexo. HCl and Pseudo.HCl in combined tablet dosage form by UV-Vis spectrophotometer and TLC. The aim of the present study is to develop and validate a new and economical method for the simultaneous estimation of Fexo. HCl and Pseudo. HCl in combine pharmaceutical tablet preparations. The method was validated in compliance with ICH guidelines [12] .
Materials and method
2.1. Chemicals and reagents. The reference standards Fexofenadine HCl and Pseudoephedrine HCl (99.4%) pure were received as a gift sample from Java Pharmaceutical Kot Lakhpat, Lahore. Organic solvents ethanol and methanol (AR grade) was procured from Merck Chemical. Distilled water was used throughout the study. Sample tablets Fexet-D (Fexo. HCl and Pseudo. HCl 60mg/120mg) were purchased from local market Lahore, Pakistan.
2.2.
Apparatus. TLC tank was used for the separation of both drugs. A single beam UV-Spectrophotometer (Cecil CE 2041, 2000 series) was used for the measurement. Analytical balance (JS-110, Japan) was used to weigh the sample and standard (Fexo. HCl and Pseudo.HCl ) material.
Selection of common solvent.
Main criteria for media selection was solubility and stability, i.e. Fexo. HCl and Pseudo. HCl should be soluble as well as stable for sufficient time in selected media. Pseudo. HCl show solubility in distilled water and ethanol (1:1) and Fexo. HCl in methanol, respectively. It is economical and hence selected for analysis.
Methodology
3.1. Thin layer Chromatograph. The grind powder of tablet was dissolved in methanol and filtered the solution with filter paper. The obtained concentrated solution was subjected on precoated silica gel plates. The polarity system CHCl 3 /n-Hexane (80:20%) was developed for TLC. The two A.P.I's were separated which showed the R f values 0.250.01 and 0.67+/-0.01 for Fexo. HCl and Pseudo. HCl , respectively. As media selection, distilled water and ethanol (1:1) were used for Pseudo. HCl and methanol for Fexo.HCl, in which both the drugs were soluble and stable for a sufficien time.
Preparation of standard stock solutions and calibration curve:
An accurately weighed 100mg each Fexo.HCl and Pseudo. HCl (reference standards) were transferred to two 100 mL volumetric flask separately and dissolved in methanol and distilled water/ethanol (1:1) individually and make up the volume up to the mark with the same solvent to obtain standard solution having concentration 1000ppm. Magnetic stirrer was used for better dissolution. Further 10ppm dissolution was made by taking 1mL from each of the above solution and make up the volume to 100mL with methanol and distilled water/ethanol (1:1). The working standard solutions 10 µg/mL of Fexo.HCl and Pseudo. HCl were scanned in the entire UV range 200-400nm to obtain the absorption spectra Fexo.
HCl and Pseudo. HCl showed maximum absorption at 220nm and 247nm, respectively. Further six dilutions from each stock solution were made with their respective solvents in the range 4-14 µg/mL and 5-30 µg/mL for Fexo. HCl and Pseudo.HCl ,respectively. The absorbance of resulting solutions were measured at respective λ max and plotted a calibration curve against concentration to get the linearity and regression equation as shown in Figures 3 and 4 .
Application of the Proposed Procedure for the Determination in
Tablets. The proposed method was applied to determine the concentration of active drug in tablets dosage form. Twenty tablets were weighed and crushed to fine powder, drug equivalent to 60 mg and 120 mg Fexo. HCl and Pseudo. HCl was weighed and taken in 100 mL volumetric flask and make up the volume with methanol and distilled water/ethanol (1:1) respectively. The above solution was filtered by using Whattmann filter paper No. 41. From the above filtrate 10 ppm solution of each active drug was made and subjected for analysis. Analysis procedure was repeated six times with tablet formulation. Aliquot was scanned in the UV range (200-400nm). The amount of drug present in the tablets was calculated from the standard graphs as given in Table 1. 3.4. Assay Measurement. The mean assay results of six sample tablets were comparable with claimed value. The obtained results are presented in Table 1 and percentage was found to be 100.1% and 100.6% respectively. 
Method Validation
The developed method was validated by following parameters as provided by ICH.
4.1. Specificity. The sample and the standard spectra were scanned to check the specificity of the method. There was not found any interference of the excipients for the determination of Fexo. HCl and Pseudo. HCl which confirmed the method is highly specified for the estimation of Fexo. HCl and Pseudo.HCl in its tablet formulation. The effect of change in wavelength was observed and mean percentage assay was calculated at two different wavelengths and was found to be very close to the proposed assay value (100.1% and 100.6 %), thus the robustness parameter was passed by the sample tablets.
4.6. Ruggedness. Ruggedness was determined by analyzing the sample preparations on two different days to check the Ruggedness of the method. The mean percentage % assay at two consecutive days was found to be very close to the proposed value (100.1% &100.6 %) respectively. HCl in its tablet formulation by proposed method were determined using calibration standards. LOD and LOQ were calculated and the results are shown in Table  11 .
Results and Discussions
Fexofenadine HCl and Pseudoephedrine HCl are used as antiallergic and nasal decongestant respectively. The present article deals with the development and which were close to the assay value 100.1% and 100.6% respectively. Precision of the method was measured which showed results for SD (99.57 %) and % RSD (99.53 %), The LOD (1.077ppm) and LOQ (3.265ppm) following ICH guidelines were measured which were found to be within limit. The proposed method was found to be specific, stable, linear, accurate, precise, and reproducible , therefore it can be used for routine quality control analysis of these drugs in either alone or in combined pharmaceutical dosage forms.
Conclusion
The present method is specific, linear and reproducible thus it can be used for routine quality control analysis of these drugs in either alone or in combined pharmaceutical dosage forms.
